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        Introduction 
  Bone morphogenetic proteins (BMPs) are members of the TGF-     
superfamily of proteins that coordinate cell proliferation, dif-
ferentiation, and survival in embryogenesis and adult tissue 
homeostasis (  Attisano and Wrana, 2002  ). BMP-2, -4, and -7 
exert their biological effects by interacting with serine/threonine 
kinase receptors BMP receptor IA (BMPRIA; ALK3) or 
BMPRIB (ALK6) and their coreceptor, BMPRII. Downstream 
signaling events include the phosphorylation of Smad1/5/8, 
interaction with comediator Smad4, nuclear translocation, and 
gene transcription. Although many of the biological effects of 
the BMPs have been related to the Smad-dependent pathways, 
Smad-independent MAPK pathways (JNK, p38, and extracel-
lular receptor-dependent kinase 1/2 [ERK1/2]) also play an ac-
tive role in BMP signaling (  Massague, 2003  ). 
  Given the range of biological functions controlled by 
BMP signaling, much effort has been directed at understand-
ing how dysfunction in this pathway contributes to the devel-
opment of disease. Idiopathic pulmonary arterial hypertension 
(PAH [IPAH]) is a disease linked to aberrant BMPRII func-
tion. Different heterozygous loss of function mutations in 
BMPRII are observed in 25% of sporadic and 70% of familial 
cases of IPAH in which the penetrance is only 20% (  Deng et al., 
2000  ;   Thomson et al., 2000  ;   Machado et al., 2001  ). However, 
reduced BMPRII expression is observed in patients with IPAH 
without a BMPRII mutation and with the more common ac-
quired forms of PAH, e.g., related to a congenital heart defect 
(  Roberts et al., 2004  ). 
  IPAH is a rare condition (one to two newly diagnosed 
cases per million people per year) with a predilection for young 
M
utations in bone morphogenetic protein (BMP) 
receptor II (BMPRII) are associated with pulmo-
nary artery endothelial cell (PAEC) apoptosis 
and the loss of small vessels seen in idiopathic pulmonary 
arterial hypertension. Given the low penetrance of BMPRII 
mutations, abnormalities in other converging signaling 
pathways may be necessary for disease development. 
We hypothesized that BMPRII supports normal PAEC 
function by recruiting Wingless (Wnt) signaling pathways 
to promote proliferation, survival, and motility. In this 
study, we report that BMP-2, via BMPRII-mediated inhibi-
tion of GSK3-    , induces     -catenin (    -C) accumulation 
and transcriptional activity necessary for PAEC survival 
and proliferation. At the same time, BMP-2 mediates 
phosphorylated Smad1 (pSmad1) or, with loss of BMPRII, 
pSmad3-dependent recruitment of Disheveled (Dvl) to 
promote RhoA  –  Rac1 signaling necessary for motility. Fi-
nally, using an angiogenesis assay in severe combined 
immunodeﬁ  cient mice, we demonstrate that both     -C  –   and 
Dvl-mediated RhoA  –  Rac1 activation are necessary for 
vascular growth in vivo. These ﬁ  ndings suggest that the 
recruitment of both canonical and noncanonical Wnt 
pathways is required in BMP-2  –  mediated angiogenesis.
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  Wnts can signal through a canonical    -catenin  (  -C) – 
dependent pathway via interaction with a receptor complex 
composed of a Frizzled protein and low density lipoprotein 
receptor  –  related protein family member (LRP5 or 6). The cyto-
plasmic protein Disheveled (Dvl) is recruited, facilitating inhi-
bition of GSK3-    . This protects     -C from ubiquitination and 
allows it to accumulate in the cytoplasm and shuttle to the nu-
cleus, where it interacts with other transcription factors and ac-
tivates genes involved in cellular maintenance, proliferation, 
and survival such as c-myc, cyclin D1, VEGF, survivin, and 
axin2 (  Bain et al., 2003  ;   Rawadi et al., 2003  ;   Logan and Nusse, 
2004  ;   Chen et al., 2005  ). Wnts can also activate noncanonical 
(i.e., non     -C dependent) signaling, the best studied of which 
is  the  Wnt – RhoA – Rac1  pathway  involved  in  tissue  polarity 
(  Axelrod and McNeill, 2002  ) and in coordinated cell movement 
during embryological development (  Habas et al., 2003  ). 
  In this study, we show that BMP-2 recruits canonical and 
noncanonical Wnt signaling pathways to promote PAEC prolif-
eration, survival, and migration. Canonical    -C – mediated  sig-
nals require BMP-2 activation of phosphorylated ERK (pERK) 
to mediate GSK3-     inactivation, whereas noncanonical signal-
ing involves BMP-2 activation of phosphorylated Smad1 
(pSmad1) to recruit Dvl and activate RhoA and Rac1. The canoni-
cal pathway depends on BMP-2  –  BMPRII interaction, whereas 
in the absence of BMPRII, BMP-2 can still promote motility by 
signaling through activin receptor IIa (ActRIIa) to mediate 
pSmad3 recruitment of Dvl to the RhoA  –  Rac1 pathway. Finally, 
we extend our observations to an in vivo model of angiogenesis 
and show, using a Matrigel plug assay in severe combined 
immunodefi  cient (SCID) mice (  Skovseth et al., 2007  ), that BMP-2 
stimulates angiogenesis in a    -C –   and  Dvl-dependent  manner. 
  Results 
  BMP-2 and Wnt3a induce proliferation, 
migration, and survival of hPAECs 
  Based on a previous study (  Langenfeld and Langenfeld, 2004  ), 
we chose to use BMP-2 as a ligand to investigate BMPRII sig-
naling in hPAECs. Endogenous production of Wnt1, -2, -3a, -4, 
-9a, and -16 in PAECs was documented using a semiquantitative 
RT-PCR to screen for all 19 Wnt family members (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200806049/DC1). 
Our decision to use Wnt3a in our experiments was based on its 
ability to activate both canonical (  Nusse and Varmus, 1992  ) and 
noncanonical (  Endo et al., 2005  ) signaling pathways. We fi  rst 
starved hPAECs for 24 h in 0.1% serum, added 10 ng/ml BMP-2 
or 100 ng/ml Wnt3a, and measured cell counts after 24 h. 
50 ng/ml VEGF-treated cells and cells exposed to 0.1% serum 
were used as positive and negative controls, respectively. Both 
BMP-2 and Wnt3a signifi  cantly increased hPAEC cell counts 
(  Fig. 1 A  ). To test the effect of the same ligands on hPAEC sur-
vival, cells were serum starved for 24 h and exposed for a fur-
ther 24 h to serum-free conditions in the presence or absence of 
BMP-2 or Wnt3a. Caspase 3/7 assays indicate that both BMP-2 
and Wnt3a reduce apoptosis when compared with vehicle-
treated controls (  Fig. 1 A  ). To investigate whether BMP-2 or 
Wnt3a also stimulates hPAEC migration, cells were seeded 
women (female/male ratio of 2.3:1) and a median age at diag-
nosis of 36.4 yr (  Rich et al., 1987  ). In the absence of treat-
ment, IPAH patients have a mean survival of 2.8 yr ( Massague, 
2003  ;   Humbert et al., 2004a  ). Both IPAH and the more com-
mon acquired forms of PAH are characterized by a progres-
sive increase in pulmonary vascular resistance, attributed to the 
loss of small peripheral pulmonary arteries resulting from 
apoptosis of endothelial cells (ECs;   Teichert-Kuliszewska 
et al., 2006  ) and occlusion of larger proximal pulmonary arter-
ies resulting from the proliferation of smooth muscle cells 
(SMCs) and deposition of the extracellular matrix. In the late 
stages of the disease, in and around some of these occluded 
vessels, aberrant EC channels can be found reflecting the 
expansion of apoptosis-resistant EC populations (  Tuder and 
Voelkel, 2002  ) that may arise from endogenous or circulating 
progenitor cells (  Asosingh et al., 2008  ). Current therapies in-
clude oral and intravenous agents with vasodilatory properties 
that improve symptoms but do not reverse or consistently pre-
vent the progression of the disease, leaving lung transplanta-
tion, with its inherent high mortality and morbidity, as the 
only choice for patients with the end-stage disease (  Humbert 
et al., 2004b  ). 
  Work in transgenic animals has facilitated our understand-
ing of the link between aberrant BMP signaling and pulmonary 
vascular pathology. Homozygous deletion of BMPRII (  Beppu 
et al., 2000  ) and BMPRIA (  Mishina et al., 1995  ) results in le-
thality during gastrulation, whereas mice heterozygous for 
BMPRII are relatively normal but can develop more severe pul-
monary hypertension and vascular remodeling when exposed to 
high levels of serotonin (  Long et al., 2006  ) or when injected 
with lipo  xygenase (  Song et al., 2005  ). 
  Experiments performed in human pulmonary artery ECs 
(PAECs [hPAECs]) show that the loss of BMPRII by RNAi 
impairs the ability of BMP-2 to enhance PAEC survival under 
proapoptotic conditions (  Teichert-Kuliszewska et al., 2006  ). 
However, hPAECs cultured from patients with IPAH and doc-
umented BMPRII mutations exhibit enhanced proliferation 
compared with ECs from healthy donors (  Masri et al., 2007  ), 
and this may account for the aberrant angiogenesis within the 
lumen and the adventitia of the vessels with plexogenic ob-
structive arteriopathy observed in advanced IPAH. However, 
cells from the IPAH patients are impaired in their ability to 
form tubelike structures in culture (  Masri et al., 2007  ), and 
this may be responsible for their inability to reconstitute the 
lost distal pulmonary vascular bed. Thus, a comprehensive 
understanding of normal regulation of EC function by BMPRII 
signaling is a necessary fi  rst step in appreciating how abnor-
malities lead to disease. 
  An interaction between BMPs and members of the Wing-
less (Wnt) signaling pathway is implicated in embryonic lung 
development, as both BMP and Wnt signaling cascades coordi-
nate stem cell fate determination and commitment to lung 
branching morphogenesis (  Chen et al., 2005  ). In other organs, 
BMPs (  Deckers et al., 2002  ;   Langenfeld and Langenfeld, 2004  ; 
  Chen et al., 2005  ;   Raida et al., 2005  ) and Wnts (  Ishikawa et al., 
2001  ;   Masckauchan et al., 2005  ) participate in angiogenesis as-
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onto Cytodex 3 carrier beads and embedded in vitronectin gels 
in the presence of BMP-2 or Wnt3a for 48 h. Both BMP-2 and 
Wnt3a promoted hPAEC migration in a manner similar to that 
seen with VEGF, the positive control, judged by the distance 
migrated from the beads (  Fig. 1 A  ). 
  BMP-2 and Wnt3a promote     -C  –  mediated 
transcriptional activity in hPAECs 
  Wnt3a is associated with canonical     -C signaling in a variety of 
cells, including ECs (  Wright et al., 1999  ). Given the similarities 
in biological responses in hPAECs, we proposed that BMP-2, 
like Wnt3a, could activate     -C signaling to induce the expres-
sion of Wnt target genes. Immunoblots using an antibody that 
recognizes the active nonphosphorylated form of     -C were per-
formed on lysates from hPAECs stimulated for 6 or 8 h with 
BMP-2 or Wnt3a. We observed that both agonists induce a sig-
nifi  cant increase in the level of active     -C within 10  –  30 min of 
stimulation (  Fig. 1 B  ). Using confocal microscopy, increased 
levels of nuclear     -C were demonstrated in BMP-2  –  stimulated 
hPAECs within 1 h (Fig. S2, available at http://www.jcb.org/
cgi/content/full/jcb.200806049/DC1). To relate the observed in-
crease in active     -C to changes in target gene transcription, we 
nucleofected cells with the lymphoid enhancer binding factor 
(LEF)/T cell  –  specifi  c transcription factor (TCF) promoter-
reporter construct (TOPfl  ash) or with the negative control plas-
mid (FOPfl  ash) followed by measurement of luciferase. After 
6 h of stimulation, luciferase was signifi  cantly elevated in TOP-
fl  ash-transfected hPAECs stimulated with either BMP-2 or Wnt3a 
when compared with unstimulated or FOPfl  ash-transfected 
cells (  Fig. 1 C  ). 
  Next, we related the Wnt3a- and BMP-2  –  induced increase 
in     -C transcriptional activity to downstream gene targets that 
could be implicated in the functional changes observed. Immuno-
blots were performed using antibodies for VEGF 121, c-myc, 
cyclin D1, and survivin, given their established role in EC pro-
liferation, survival, and migration (  He et al., 1998  ;   Tetsu and 
McCormick, 1999  ;   Zhang et al., 2001a,b  ). Lysates obtained up 
to 4 h after stimulation with either agonist showed an increase 
in the levels of these proteins (  Fig. 1 D  ). 
  Reduction of     -C decreases BMP-2  –   and 
Wnt3a-induced hPAEC proliferation and 
survival but enhances migration 
  Because BMP-2 and Wnt3a increase     -C transcriptional activity 
and target proteins potentially involved in hPAEC prolifera-
tion, survival, and migration, we next determined whether 
    -C was necessary for these functions. hPAECs were nucleo-
fected with siRNA duplexes designed against    -C,  which 
achieved an     75% knockdown of total     -C protein 24 h after 
  Figure 1.       BMP-2 and Wnt3a promote proliferation, migration, and sur-
vival of hPAECs while increasing     -C transcriptional activity and target 
genes.   (A) Cell count, caspase 3/7 apoptosis, and microcarrier bead mi-
gration assays of hPAECs in the presence or absence of 10 ng/ml BMP-2 
or 100 ng/ml Wnt3a. Serum-free conditions were used to induce apop-
tosis, whereas 50 ng/ml of recombinant human VEGF was used as a 
positive control for proliferation and motility. (B) Representative Western 
immunoblots (top) and densitometry values (bottom) for     -C normalized to 
    -tubulin in response to BMP-2 and Wnt3a stimulation as in A. (C) TOP-
ﬂ  ash luciferase assays. hPAECs were transfected with TOPﬂ  ash or FOPﬂ  ash 
(negative control) luciferase reporter plasmids or Renilla (control for trans-
fection efﬁ  ciency). 6 h after stimulation with BMP-2 and Wnt3a, lysates 
were analyzed for luciferase activity relative to Renilla. CON, control. 
(D) Representative immunoblots for c-myc, VEGF, cyclin D1, and survivin 
in lysates of hPAEC stimulated with Wnt3a or BMP-2 as described in A. 
Values were normalized for     -tubulin. Error bars represent mean   ±   SEM 
from four different experiments performed in triplicate. *, P   <   0.01; **, 
P   <   0.001; ***, P   <   0.0001 (vs. unstimulated control).     
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transfection (  Fig. 2 A  ). Cell counts (  Fig. 2 B  ) show that    -C 
siRNA  –  treated hPAECs failed to exhibit the increased prolif-
erative response to BMP-2 and Wnt3a compared with hPAECs 
transfected with nontargeting siRNA. Our survival experiments 
showed that the loss of     -C reversed the survival advantage 
induced by BMP-2 and Wnt3a in response to serum depriva-
tion (  Fig. 2 C  ). However, the loss of     -C enhanced BMP-2  –   
and Wnt3a-mediated motility (  Fig. 2 D  ). These fi  ndings raised 
the possibility that both Wnt3a and BMP-2 could be simul-
taneously activating a    -C – independent  pathway  necessary 
for cell motility. 
  BMPRII knockdown reduces proliferation 
and survival but promotes migration 
  Mutations in BMPRII in IPAH result in loss of expression and 
function (  Humbert et al., 2004a  ). To study the biological impact 
of BMPRII defi  ciency on hPAEC proliferation, migration, and 
survival, we performed knockdown experiments using a pool of 
siRNA designed against the BMPRII sequence and achieved an 
    75% reduction in protein levels at 24 h (  Fig. 3 A  ). This was 
also associated with a reduction in TOPfl  ash activity under 
baseline conditions and in response to BMP-2 (  Fig. 3 B  ). 
  In the setting of BMPRII knockdown, hPAECs failed to 
proliferate in response to BMP-2 when compared with con-
trols. However, when hPAECs were stimulated with Wnt3a or 
VEGF, BMPRII knockdown had no signifi  cant effect on prolif-
eration (  Fig. 3 C  ). Similarly, the protection against apoptosis 
conferred by BMP-2 was lost with the knockdown of BMPRII, 
but this did not affect the response to Wnt3a (  Fig. 3 D  ). How-
ever, the loss of BMPRII, similar to the loss of     -C, resulted in 
an increase in BMP-2  –   but not Wnt3a-mediated hPAEC motil-
ity (  Fig. 3 E  ). 
  Therefore, we performed experiments to (a) address how 
BMP-2 via BMPRII might be stimulating     -C gene regulation to 
infl  uence proliferation and survival and (b) establish how BMP-2 
can regulate cell motility by using a    -C – independent  pathway. 
  BMP-2 increases     -C via BMPRII-dependent 
pERK1/2 inhibition of GSK3-     
  The regulation of     -C levels in mammalian cells is largely de-
pendent on targeted phosphorylation by GSK3-     followed  by 
ubiquination and proteasomal degradation (  Logan and Nusse, 
2004 ).  GSK3-    can be inactivated by targeted phosphorylation 
of serine 9 or 21, allowing the accumulation of    -C  ( Cohen  and 
Frame, 2001  ). Several kinase pathways are known to inhibit 
GSK3-    , among which IP3/Akt, p38, and ERK1/2 are the best 
studied (  Cohen and Frame, 2001  ;   Ding et al., 2005  ;   Thornton 
et al., 2008  ). Given that BMPs are known to activate these same 
pathways through Smad-independent mechanisms (  Sugimori 
et al., 2005  ;   Jin et al., 2006  ), we investigated whether BMP-2  –
  mediated activation of Akt, ERK1/2, and p38 occurred in 
hPAECs concomitant with GSK3-     inactivation.  We  observed 
no change in the BMP-2  –  mediated phosphorylation of Akt and 
p38 (unpublished data) in contrast to a rapid induction of 
ERK1/2 phosphorylation. To determine whether BMP-2 via 
BMPRII mediates pERK1/2 and whether pERK1/2 is neces-
sary for     -C accumulation and transcriptional activity, we 
  Figure 2.       Knockdown of     -C reduces the proliferation and survival 
response of hPAECs to BMP-2 and Wnt3a but enhances their migratory 
response.   (A) Western immunoblots for     -C and     -tubulin of hPAECs 
nucleofected with nontargeting control (CON RNAi) and     -C  –  speciﬁ  c 
siRNA (    C RNAi). ***, P   <   0.0001 (compared with nontargeting con-
trol). (B  –  D) Cell proliferation (B), caspase 3/7 activity (C), and cell 
migration (D) assays using cells nucleofected with nontargeting or 
    -C  –  speciﬁ  c siRNA were performed as in Fig. 1. Error bars represent 
mean   ±   SEM from three different experiments performed in triplicate. 
**, P   <   0.001 (BMP-2 or Wnt3a vs. unstimulated nontargeting control); 
#, P   <   0.01 and ##, P   <   0.001 (    -C  –  speciﬁ  c siRNA vs. corresponding 
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  Figure 3.       Knockdown of BMPRII reduces BMP-2  –  mediated proliferation and survival of hPAECs but enhances their migratory response.   (A) Western 
immunoblots for BMPRII and     -tubulin in hPAECs nucleofected with nontargeting control (CON RNAi) and BMPRII siRNA (BMPRII RNAi). Error bars denote 
mean   ±   SEM for three different assessments. ***, P   <   0.0001 (vs. nontargeting control). (B) TOPﬂ  ash activity assay. **, P   <   0.001 (vs. nontargeting 
control); ##, P   <   0.001 (vs. BMP-2  –  stimulated nontargeting control). (C  –  E) Cell proliferation (C), caspase 3/7 activity (D), and cell migration (E) assays 
using cells nucleofected with nontargeting or BMPRII-speciﬁ  c siRNA as in Fig. 1. (B  –  E) Error bars represent mean   ±   SEM from three different experi-
ments performed in triplicate. *, P   <   0.01 and **, P   <   0.001 (vs. unstimulated nontargeting control); ##, P   <   0.001 (vs. BMP-2  –   or Wnt3a  –  stimulated 
nontargeting control).     JCB • VOLUME 184 • NUMBER 1 • 2009  88
hPAECs (  Fig. 4 B  ). To address whether BMP-2 might be medi-
ating     -C accumulation through the production and extracellu-
lar release of Wnts, we treated hPAECs with 500 ng/ml DKK 1. 
DKK 1 interacts with LRP 5/6 to interfere with receptor com-
plex formation and Wnt-induced signal transduction (  Glinka 
et al., 1998  ). There was no reduction in the BMP-2  –  induced ac-
cumulation of     -C in either carrier or DKK 1  –  treated hPAECs 
( Fig.  4  C ). 
  BMP-2 and Wnt3a activate GTPases RhoA 
and Rac1 
  Although our aforementioned fi  ndings indicate that BMP-2 via 
BMPRII can recruit     -C to regulate proliferation and survival of 
hPAECs, they do not explain the BMPRII- and    -C – independent 
mechanism involved in BMP-2  –  mediated hPAEC motility. As 
shown in one study, Wnt3a can signal via the    -C – independent 
RhoA  –  Rac1 pathway to coordinate embryological events such as 
gastrulation (  Habas et al., 2003  ). In CHO and neuronal cells, this 
pathway promotes cytoskeletal changes that facilitate cell migra-
tion through the formation of lamellipodia and fi  lo  podia (  Boutros 
et al., 1998  ;   Habas et al., 2003  ;   Kishida et al., 2004  ;   Endo et al., 
2005 ).  Activation  of  the  Wnt – RhoA – Rac1  pathway  leads  to  tar-
geted induction of downstream proteins like LIM domain kinase 
(LIMK) and ROCK I/II, which are involved in stabilization of the 
actin cytoskeleton and actin  –  myosin contraction, respectively 
(  Yang et al., 1998  ;   van Nieuw Amerongen and van Hinsbergh, 
2001  ;   Sandquist et al., 2006  ). 
  Using pull-down assays to precipitate the active forms of 
RhoA and Rac1, we showed a signifi  cant increase in active RhoA 
and Rac1 over a 4-h period in hPAECs stimulated with both 
stimulated control and BMPRII siRNA  –  treated hPAECs with 
BMP-2 for 1 h. The coincidental increase in pERK1/2 with 
phosphorylation (i.e., inactivation) of GSK3-     and  subsequent 
accumulation of     -C was abrogated in cells treated with BMPRII 
siRNA (Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200806049/DC1). As a control, we showed that hPAECs 
treated with BMPRII siRNA responded to Wnt3a stimulation 
by an increase in both    -C  and  TOPfl  ash transcriptional activ-
ity (unpublished data). 
  To determine a requirement for pERK1/2 in the regulation 
of GSK3-     activity, we incubated hPAECs with BMP-2 in the 
presence of PD98059, a known inhibitor of the ERK1/2 pathway. 
We show that BMP-2 fails to activate ERK1/2 when PD98059 is 
present and that this is associated with both a lack of GSK3-    
phosphorylation and accumulation of     -C (  Fig. 4 A  ). Similar re-
sults were obtained using a dominant-negative (   )  ERK  con-
struct (adenoviral vector containing a FLAG-tagged ERK2-AEF 
construct with mutated phosphorylation sites; Fig. S4 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200806049/DC1). 
The lack of     -C accumulation with BMP-2 stimulation also 
correlated with suppressed     -C transcriptional activity, as indi-
cated by reduced TOPfl  ash reporter activity in the presence of 
PD98059 (Fig. S4 B). 
 Although  BMP-2 – mediated     -C activation appears to be 
dependent on ERK1/2 activation, we also investigated the po-
tential contribution of pSmads (  Labbe et al., 2000  ) and/or auto-
crine Wnt signaling (  Fischer et al., 2002  ) in this process. We 
found that BMP-2  –  mediated     -C accumulation in hPAECs trans-
fected with either a dominant-negative (    ) Smad1 or Smad3 
construct in a manner similar to that of vector-only transfected 
  Figure 4.       BMP-2 activation of     -C transcriptional activity in hPAECs is dependent on ERK.   (A) Western immunoblots of hPAECs stimulated with BMP-2 in the 
presence or absence of 10   μ  M PD98059. Blots were probed for pERK, total ERK, GSK3-    , and     -C. (B) Western immunoblots of hPAECs transfected with 
dominant-negative (    ) Smad1 or -3 constructs and stimulated with 10 ng/ml BMP-2 for 1 h. Blots were probed for active     -C and     -tubulin as a loading 
control (CON). (C) Western immunoblots of hPAECs incubated with 10 ng/ml BMP-2 in the presence or absence of 500 ng/ml DKK 1 for 1 h. Blots 
were probed for active     -C and     -tubulin as a loading control. Error bars denote mean   ±   SEM for three different experiments performed in triplicate. 
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(  Fig. 6 D  ). As predicted by our previous experiments, this did not 
occur in cells transfected with either DEP+ or    DEP  Dvl-GFP. 
To show that the effects of the Dvl constructs were indepen-
dent of   -C signaling, we probed the lysates of BMP-2 – stimulated 
hPAECs transfected with each of the Dvl constructs for changes 
in     -C accumulation. We found no impairment in the    -C  re-
sponse under any experimental condition, providing further evi-
dence that canonical signaling is not required for the modu lation 
of hPAEC motility (Fig. S5 A, available at http://www.jcb.org/
cgi/content/full/jcb.200806049/DC1). 
  BMP-2 mediates relocation of Dvl from the 
perinuclear region to the cell membrane 
  Several lines of evidence suggest that participation in RhoA  –
  Rac1 signaling requires relocation of Dvl to the cell membrane 
to engage in signaling complexes (  Yu et al., 2007  ). To provide 
evidence to support this feature in hPAECs, we used immuno-
fl  uorescence and confocal microscopy to identify changes in 
Dvl after BMP-2 and Wnt3a stimulation and found that the dis-
tribution of Dvl changes to enter fi  lopodia and lamellipodia 
after BMP-2 and Wnt3a stimulation (Fig. S5 B). 
  Confocal images of cells transfected with WT and mutant 
GFP-labeled constructs were used to examine the peripheral 
versus central localization of Dvl in response to BMP-2 stimu-
lation and were quantifi  ed as described in Materials and meth-
ods ( Fig. 6 E ). After stimulation with BMP-2, both WT Dvl-GFP 
and     DIX Dvl-GFP (  Fig. 6 E  , green) extend into lamellipodia 
and fi  lopodia and co-distribute with actin on the cell membrane 
(  Fig. 6 E  , yellow); i.e., a signifi  cant increase in peripheral to 
central distribution of Dvl is apparent. BMP-2  –  stimulated and 
nonstimulated hPAECs transfected with     DEP Dvl-GFP show 
discrete fl  uorescent granules in a perinuclear distribution with 
limited formation of lamellipodia (  Fig. 6 E  ) and no peripheral 
redistribution. Cells transfected with the DEP+ Dvl-GFP con-
struct show intense peripheral redistribution of Dvl on the cell 
BMP-2 and Wnt3a (  Fig. 5  ). The activation of RhoA and Rac1 
temporally coincided with the increase in    -C  activity,  support-
ing the concomitant use of both canonical and noncanonical 
signaling by BMP-2 and Wnt3a. 
  BMP-2 and Wnt3a activation of RhoA and 
Rac1 requires Dvl 
  Dvl is a necessary intermediate in the signaling of both canoni-
cal and noncanonical Wnt pathways (  Boutros et al., 1998  ;   Logan 
and Nusse, 2004  ). It appears that the selection of either signaling 
pathway is dependent on the availability of the specifi  c Dvl do-
mains DIX, PDZ, and DEP (  Axelrod et al., 1998  ;   Boutros et al., 
1998  ;   Li et al., 1999  ;   Wang et al., 2006  ). Although DIX and PDZ 
are mainly involved in canonical signaling, DEP appears to be 
required in noncanonical functions ( Axelrod et al., 1998 ;  Boutros 
et al., 1998  ;   Moriguchi et al., 1999  ;   Wang et al., 2006  ). To show 
that RhoA and Rac1 activation in hPAEC is linked to BMP-2 via 
Dvl, we transfected GFP-tagged Dvl constructs containing vari-
ous truncated versions of the protein (  Fig. 6 A  ) and assessed 
their impact on RhoA  –  Rac1 activation. As shown in   Fig. 6 
(B and C) , cells transfected with wild-type (WT) Dvl-GFP or   DIX 
Dvl-GFP show increased RhoA and Rac1 activity when stimu-
lated with BMP-2. However, in    DEP  Dvl-GFP – transfected 
cells, there is evidence of blunted RhoA activation and failure to 
activate Rac1. In DEP+ Dvl-GFP there is also no signifi  cant in-
crease in RhoA with BMP-2 stimulation; although basal levels 
of active Rac1 are elevated, there is no further increase with 
BMP-2. This indicates that in addition to the DEP domain, the 
PDZ domain is necessary to activate normal RhoA  –  Rac1 activ-
ity in response to BMP-2. 
  We assessed cell motility in hPAEC transfected with the 
Dvl-GFP constructs seeded onto microcarrier beads and ex-
posed to BMP-2 for 48 h. Cells carrying either the WT Dvl-GFP 
or     DIX Dvl-GFP construct exhibited a signifi  cant migra-
tory response to BMP-2 compared with nonstimulated cells 
  Figure 5.       BMP-2 and Wnt3a increase levels 
of active RhoA and Rac1 in hPAECs.   Active 
RhoA and Rac1 pull-down experiments were 
performed on hPAECs starved for 24 h fol-
lowed by incubation with 10 ng/ml BMP-2 
or 100 ng/ml Wnt3a for 1 and 4 h. Repre-
sentative immunoblots for RhoA and Rac1 are 
shown along with densitometry. Levels of ac-
tive RhoA and Rac1 were measured against 
total RhoA and Rac1 in cell lysates. Error bars 
denote mean   ±   SEM for three different experi-
ments with triplicate assessments. *, P   <   0.01 
and **, P   <   0.001 (vs. control [CON]).     JCB • VOLUME 184 • NUMBER 1 • 2009  90
membranes, but the formation of lamellipodia is blunted, and 
fi  lopodia are not observed. 
  Dvl relocation to lamellipodia and ﬁ  lopodia 
related to BMP-2  –  induced hPAEC motility 
  To show that Dvl relocation is required for BMP-2  –  induced 
hPAEC motility, hPAECs transfected with Dvl-GFP constructs 
were seeded in borosilicate sterile dual-chamber slides at a den-
sity of 15,000 cells per well. Using time-lapse video micros-
copy, we followed the movement of cells transfected with 
Dvl-GFP for   >  10 h. BMP-2  –  stimulated hPAECs moved faster 
and covered a larger distance compared with the unstimulated 
controls (  Fig. 7, A and C  ). The captured images also show that 
in the presence of BMP-2, Dvl-GFP shifts to the migrating front 
end of the cells and concentrates at locations rich in fi  lopodia 
and lamellipodia (  Fig. 7 A   and Videos 1 and 2, available at 
http://www.jcb.org/cgi/content/full/jcb.200806049/DC1). This 
feature is lost in the BMP-2  –  stimulated mutant    DEP  Dvl-
GFP  –  transfected cells (  Fig. 7 B   and Videos 3 and 4). These cells 
also fail to increase distance traveled and speed despite stimula-
tion with BMP-2 (  Fig. 7 C  ). 
  BMP-2 regulation of Dvl-induced RhoA and 
Rac1 motility is Smad1 dependent 
  It remained to be determined how BMP-2 can regulate Dvl-
mediated activation of RhoA and Rac1. A recent study in bone 
marrow stromal cells has shown that Smad1, one of the three 
Smads associated with the BMP signaling, can interact with 
Dvl and suppress Wnt canonical activity by preferentially 
shuttling Dvl away from the proteins that promote the phos-
phorylation of     -C (  Liu et al., 2006  ). Because BMP-2 medi-
ates Smad1 activation in human aortic and umbilical venous 
ECs (  Langenfeld and Langenfeld, 2004  ), we reasoned that in 
hPAECs, BMP-2 regulates Dvl activity via Smad1. Therefore, 
we transfected hPAECs with a construct encoding a dominant-
negative Smad1 (    Smad1) and investigated whether this would 
interfere  with  BMP-2 – mediated  RhoA – Rac1  activation  and 
motility. This Smad1 mutant contains a replacement of four 
amino acids, SSVS to AAVA, in exon 7 in the C terminus and 
thus cannot be phosphorylated; this same construct is also un-
able to bind to Dvl in immunoprecipitation assays (  Liu et al., 
2006  ). Pull-down assays show that in the setting of    Smad1, 
hPAECs stimulated by BMP-2 fail to activate RhoA or Rac1 
(  Fig. 8 A  ). Consistent with this observation, microcarrier bead 
assays show that hPAECs expressing     Smad1 also fail to 
  Figure 6.       BMP-2 recruits the PDZ and DEP domains of Dvl to activate 
RhoA and Rac1 and induce hPAEC motility.   (A) Diagram illustrating the 
structure of the four Dvl-GFP constructs used in the experiments described in 
this study. (B and C) Dvl constructs illustrated in A were individually nucleo-
fected in hPAECs to assess impact on RhoA (B) and Rac1 (C) activation in 
the presence of 10 ng/ml BMP-2. Pull-down experiments were performed 
and analyzed as in Fig. 5. Error bars denote mean   ±   SEM for three differ-
ent experiments with triplicate assessments. *, P   <   0.01 and **, P   <   0.001 
(vs. control [CON]). (D) Microcarrier bead migration assay of hPAECs 
nucleofected with Dvl constructs and exposed to BMP-2 as in A. ***, P   <   
0.0001 (vs. WT and     DIX unstimulated). (E) Representative confocal im-
ages of hPAECs nucleofected with GFP-tagged Dvl constructs. Cells were 
starved for 24 h and incubated with BMP-2 as in B. Actin was labeled 
with Alexa Fluor 555  –  phalloidin (red), and nuclei were stained with DAPI 
(blue). Quantiﬁ  cation of Dvl distribution in the cytoplasm and the periphery 
was performed as described in Materials and methods. ***, P   <   0.0001 
(vs. baseline). (D and E) Error bars denote mean   ±   SEM for three different 
experiments with quadruplicate assessments. Bars, 10   μ  m.     
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setting of reduced BMPRII availability, BMP-2 can still re-
cruit Dvl by activating Smad3. 
  We show that in BMPRII-defi  cient cells, BMP-2 fails to 
activate pSmad1 but activates pSmad3 ( Fig. 8 C ). To link Smad3 
activation with signaling through the alternate BMP-2 receptor 
ActRIIa, we cotransfected siRNA for BMPRII and ActRIIa (or 
a nontargeting control) into hPAECs and harvested cell lysates 
over 1 h. We achieved an 80% knockdown of ActRIIa, which is 
comparable with that for BMPRII (unpublished data). BMP-2  –
  mediated activation of Smad3 is lost in cells defi  cient in both 
BMPRII and ActRIIa (  Fig. 8 D  ). 
  To test the functional relevance of this alternate pathway 
in preserving BMP-2  –  mediated hPAEC migration, we trans-
fected hPAECs with either a dominant-negative Smad3 (  Smad3) 
or an empty vector. This     Smad3 has been shown in one study 
to be unable to interact with Dvl or to be phosphorylated by 
TGF-     receptors ( Warner et al., 2005 ). Microcarrier bead assays 
migrate in response to BMP-2 (  Fig. 8 B  ), further supporting 
the need for functional Smad1. 
  BMP-2 promotes motility of BMPRII-
deﬁ  cient hPAECs by pSmad3 activation 
via ActRIIa, a member of the TGF-     
receptor superfamily 
 In cells with reduced BMPRII, enhanced migration in response 
to BMP-2 suggested an alternate signaling pathway, resulting 
in increased noncanonical activity. Although Smad1/5/8 acti-
vation is markedly reduced in the setting of BMPRII muta-
tions (  Yang et al., 2005  ), BMPs can still signal in human 
pulmonary artery SMCs by recruiting BMPRIA and ActRIIa, 
another member of the TGF-     family of receptors (  Yu et al., 
2005  ). The ActRs are known to signal using Smad2 and -3. 
Moreover, Smad3 can interact with Dvl in mammalian cells 
(  Warner et al., 2005  ). Therefore, we hypothesized that in the 
  Figure 7.       BMP-2 facilitates redistribution of Dvl to ﬁ  lopodia and lamellipodia in hPAECs.   (A and B) Live images taken over a 10-h period of cells nucleo-
fected with Dvl-GFP (A) or     DEP Dvl-GFP (B) and stimulated with either vehicle or 10 ng/ml BMP-2. Arrowheads indicate the marked presence of GFP 
signal in the migrating front end of Dvl-GFP  –  transfected cells incubated with BMP-2. See Videos 1  –  4 (available at http://www.jcb.org/cgi/content/full/
jcb.200806049/DC1). (C) The distance and speed of control and BMP-2  –  stimulated cells transfected with Dvl-GFP and     DEP Dvl-GFP. Distance was 
measured by plotting the coordinates of the nuclei every 10 min for 10 h and adding the distance between the points. Speed was calculated by dividing 
the distance over time (10 h). Error bars denote mean   ±   SEM for three different experiments with triplicate assessments. ***, P   <   0.001 (vs. baseline). 
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show that cells containing both BMPRII knockdown and   Smad3 
failed to respond to BMP-2 stimulation, whereas those cells 
with BMPRII knockdown alone exhibited enhanced motility 
(  Fig. 8 E  ). Thus, in the setting of reduced BMPRII, the activa-
tion of Smad3 by BMPRII-independent pathways compensates 
for reduced Smad1 signaling to preserve hPAEC motility. 
  BMP-2  –  mediated angiogenesis in SCID 
mice requires canonical and noncanonical 
Wnt pathways 
  Angiogenesis requires coordinated endothelial proliferation, 
migration, and alignment to form functional tubular structures 
(  Adams and Alitalo, 2007  ). Current cell culture approaches 
cannot fully reproduce the complex biological environment 
where vessel growth occurs. For this reason, we applied a well-
established angiogenesis assay to study the impact of BMP-2  –
  mediated canonical and noncanonical signaling in the intact 
mouse (  Skovseth et al., 2002  ,   2007  ). We implanted Matrigel 
plugs containing hPAECs transfected with either    -C  siRNA  or 
nontargeting siRNA into SCID mice and, 14 d later, assessed 
the formation of microvessels, the presence of murine  –  human 
hybrid endothelial tubes, and the number of murine and human 
ECs within the plugs (see Materials and methods). Compared 
with the baseline (  Fig. 9, A and E  ), BMP-2  –  enriched Matrigel 
plugs (  Fig. 9, B and F  ) containing hPAECs transfected with 
nontargeting siRNA exhibited greater numbers of both hPAECs 
and murine ECs ( Fig. 9 I ). In addition, vascular tubes comprised 
of both murine and human cells (mean of two tubes per 40  ×   
high power fi  eld) and microvessels containing red blood cells 
(mean of two to three microvessels per 40  ×   high power fi  eld) 
were exclusively seen in this experimental group (  Fig. 9, B and F  ). 
In contrast, BMP-2  –  enriched Matrigel plugs containing    -C – 
defi  cient cells (  Fig. 9, C and G  ) showed neither hybrid micro-
vessels nor an expansion of the hPAECs. Interestingly, in these 
plugs, the number of murine ECs increased in response to 
BMP-2 (  Fig. 9 I  ). 
 To study the impact of dysfunctional noncanonical Wnt sig-
naling on angiogenesis, we implanted Matrigel plugs containing 
hPAECs transfected with the dominant-negative Dvl construct 
    DEP into SCID mice. After 14 d, despite a signifi  cant murine 
and human EC growth response to BMP-2 compared with un-
stimulated controls, no evidence of microvessels or hybrid tube 
formation was found (  Fig. 9, D, H, and J  ). Collectively, these ex-
periments show that in vivo, BMP-2 stimulates an angiogenic 
response by recruiting canonical and noncanonical Wnt signal-
ing pathways. 
  Figure 8.       Recruitment of Dvl by BMP-2 requires Smads and is indepen-
dent of BMPRII functional status.   (A) Active RhoA and Rac1 pull-down ex-
periments on hPAEC nucleofected with either vector or dominant-negative 
(    ) Smad1 construct and incubated with 10 ng/ml BMP-2 were analyzed 
as described in Fig. 6. **, P   <   0.001 (vs. control [CON]). (B) Microcar-
rier bead assay using hPAECs nucleofected with vector (V) or     Smad1 
was performed as in Fig. 6 D. ***, P   <   0.0001 (vs. control); ##, P   <   
0.001 (vs. vector only stimulated with BMP-2). (C) Western immunoblots of 
BMP-2  –  stimulated hPAECs transfected with BMPRII siRNA or nontargeting 
control siRNA. Blots were probed for phosphorylated and total Smad1 
and -3. **, P   <   0.001 and ***, P   <   0.0001 (vs. control). (D) Western 
immunoblots of hPAECs transfected with siRNA for both BMPRII and ActRIIa 
followed by stimulation with 10 ng/ml BMP-2 for 1 h. Blots were probed 
for phosphorylated and total Smad1 and -3. **, P   <   0.001 and ***, 
P   <   0.0001 (vs. control). (E) Microcarrier bead assay using hPAECs nucleo-
fected with BMPRII siRNA along with vector or dominant-negative Smad3 
(    Smad3). **, P   <   0.001 (BMP-2  –  stimulated vector or     Smad3 vs. respec-
tive unstimulated control RNAi); +++, P   <   0.0001 (BMP-2  –  stimulated vs. 
unstimulated BMPRII RNAi vector or     Smad3); ###, P   <   0.0001 (vector vs. 
    Smad3). Error bars denote mean   ±   SEM for three different experiments 
with triplicate assessments.     
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in patients with IPAH, these fi  ndings may help better under-
stand aberrant angiogenesis in disorders such as malignancy 
and may lead to new opportunities to stimulate the growth of 
new blood vessels in disease and in tissue regeneration. 
  The loss of ECs in larger arteries has been linked to the 
stimulation of SMC proliferation through the release of active 
TGF-     (  Sakao et al., 2006  ). In addition, the emergence of apop-
tosis-resistant ECs that proliferate and migrate much more ro-
bustly than ECs of healthy donors (  Masri et al., 2007  ) may 
account for the aberrant angiogenesis within the lumen and the 
adventitia of the vessels with plexogenic obstructive arteriopa-
thy observed in advanced IPAH. However, cells from the IPAH 
patients are impaired in their ability to form tubelike structures 
in culture (  Date et al., 2004  ;   Masri et al., 2007  ), and this may 
account for their inability to reconstitute the lost distal pulmo-
nary vascular bed. In unpublished data, we have evidence that 
  Discussion 
  The loss of small precapillary arteries is a feature of IPAH and 
secondary forms of PAH and is thought to result from injury 
and susceptibility of ECs to apoptosis. Previous studies have 
linked the loss of BMPRII to the development of IPAH and to 
the propensity of ECs to apoptose (  Teichert-Kuliszewska et al., 
2006  ;   Masri et al., 2007  ). Our study looks into why that occurs 
and whether the same mechanisms might explain other features 
necessary for vascular regeneration, i.e., proliferation and mi-
gration. In this study, we report for the fi  rst time to our knowl-
edge that a BMPRII ligand recruits a canonical Wnt signaling 
pathway to promote hPAEC survival and proliferation by acti-
vating ERK1/2 and stimulates a Dvl-mediated noncanonical 
RhoA  –  Rac1 pathway to induce migration by activating Smad1. 
Beyond uncovering mechanisms that relate to the loss of vessels 
  Figure 9.       Recruitment of both canonical and noncanonical signaling pathways is required for BMP-2  –  induced microvessel formation in SCID mice.   (A  –  H) 
Representative immunoﬂ  uorescence (A  –  D) and H  &  E (E  –  H) images show the appearance of unstimulated (A and E) and BMP-2  –  stimulated (B and F) controls 
and     -C RNAi  –  treated (C and G) and     DEP Dvl  –  transfected (D and F) cells 14 d after implantation into SCID mice. Human and murine CD31 are labeled 
with green and red ﬂ  uorescent antibodies, respectively, and nuclei are stained blue with DAPI. Hybrid vessels containing green and red ECs (B) in associa-
tion with RBC-ﬁ  lled vessels (F) are seen under conditions of BMP-2 stimulation (arrows) but not when the hPAECs were transfected with     -C RNAi (C and G) 
or with     DEP (D and H). (I and J) Quantitative analysis of the mean number of human (H) and murine (M) cells found per 40  ×   ﬁ  eld. Comparisons are made 
between unstimulated control and     -C RNAi  –  treated (I) or     DEP-transfected (J) versus BMP-2  –  stimulated counterparts. Error bars denote mean   ±   SEM for 
four different experiments. *, P   <   0.01; **, P   <   0.001; ***, P   <   0.0001 (vs. same lineage control [CON]; human or murine). ##, P   <   0.001; ###, P   <   0.0001 
(human vs. murine). +++, P   <   0.0001 (lineage-speciﬁ  c control vs. experimental [    C RNAi or     DEP]). Bars: (A  –  D) 10   μ  m; (E  –  H) 30   μ  m.     JCB • VOLUME 184 • NUMBER 1 • 2009  94
  Our experiments showing heightened hPAEC migration in 
response to both BMP-2 and Wnt3a suggested that both ligands 
might be using a non  –     -C – dependent  Wnt  signaling  pathway. 
Wnt3a can recruit Dvl to activate RhoA and Rac1 (  Kishida 
et al., 2004  ;   Endo et al., 2005  ), which are small GTPases that 
coordinate features of cell motility (i.e., the cytoskeletal re-
arrangements that permit retraction of the base of the cell and 
extension of the leading front through the formation of lamelli-
podia and fi  lopodia). 
  This study shows not only that Dvl is recruited by BMP-2 
but that this process is pSmad dependent. The highly conserved 
PDZ and DEP domains in Dvl that were previously identifi  ed 
in   Drosophila    melanogaster   as required for RhoA  –  Rac1 signaling 
and cell motility (  Axelrod et al., 1998  ;   Wang et al., 2006  ) are nec-
essary for BMP-2 to induce hPAEC migration. Thus, a potential 
way in which pSmads could modulate the switch between canoni-
cal and noncanonical signaling would be through their ability to 
interact with the DIX domain of Dvl. This would limit the inter-
action of Dvl with protein partners necessary for    -C  activation 
while exposing the PDZ and DEP domains to facilitate RhoA  –
  Rac1 activation and cell motility. 
  How Dvl is partitioned between canonical and noncanoni-
cal signaling is not currently known, but it is possible that the in-
teraction between Dvl and pSmads occurs in a different subcellular 
compartment segregating this pool of Dvl from that available for 
canonical activity. Consistent with this idea is the observation that 
Dvl accumulates either in vesicles (  Capelluto et al., 2002  ) or as-
sociates with actin (  Torres and Nelson, 2000  ). 
  An unexpected fi  nding was that BMP-2 could control motil-
ity despite reduced BMPRII. We found that when BMPRII is lack-
ing, BMP-2, using receptor complexes containing BMPRIA/B 
and the TGF-     superfamily receptor ActRIIa, signals via 
Smad2/3 to preserve motility in hPAECs. A similar interaction of 
BMPRIA with ActRIIa was observed with deletion of BMPRII 
in pulmonary arterial SMCs (  Yu et al., 2005  ), but the functional 
consequences of the altered signaling were not investigated. 
Mutations in TGF-     receptors can also contribute to the develop-
ment of PAH in patients with hemorrhagic hereditary telangiecta-
sia (  Cottin et al., 2007  ). However, whether mutations in other 
members of the TGF-     receptor superfamily compound the 
propensity to PAH when there is BMPRII loss of function is still 
unclear. In ECs isolated from plexogenic lesions, a reduction in 
TGF-    -RII was found, suggesting that abnormal signaling via 
this receptor may contribute to the development of vascular 
pathology (  Yeager et al., 2001  ). 
  It would be of interest to further investigate the role of the 
planar cell polarity receptors in BMP-2  –   and Wnt3-mediated 
noncanonical Dvl  –  RhoA  –  Rac1 signaling to assess whether this 
pathway is important in establishing EC polarity and in recruit-
ing pericytes and whether these particular features are BMPRII 
dependent. This pathway is critical in convergent extension; i.e., 
the medial convergence and intercalation of elongated mesen-
chymal cells along the anteroposterior axis that leads to elonga-
tion and narrowing of the body axis. Indeed, the orderly bran ching 
morphogenesis observed in normal angiogenesis in the lung and 
in other tissues strongly suggests that planar cell polarity signal-
ing may be present (  Lamalice et al., 2007  ). 
these apoptosis-resistant ECs may have constitutive signaling 
via     -C, as occurs with oncogenic    -C  ( Peifer,  1997 ). 
  Although our study shows that pERK1/2, and not 
p    Smad1/5/8 or pSmad2/3, is necessary for     -C accumulation, it 
does not exclude the possibility that other signaling molecules 
activated or inhibited by BMPs might also play a role in mediat-
ing     -C accumulation. Besides pERK1/2 (  Ding et al., 2005  ), 
BMPs can trigger Smad-independent signaling using kinase 
pathways such as JNK, which could also target GSK3-     for inhi-
bition (  Moule et al., 1997  ;   Cohen and Frame, 2001  ;   Ding et al., 
2005  ). BMP signaling has also been shown to activate the MAPK 
TAK1 (  Yamaguchi et al., 1995  ) that targets NEMO-like kinase 
(NLK), an endogenous inhibitor of canonical Wnt signaling that 
acts by interfering with DNA binding of the    -C – TCF  transcrip-
tional complex (  Ishitani et al., 1999  ,   2003  ). Although our results 
support the ability of BMP-2 to enhance     -C activity in hPAECs, 
it may be possible that the BMP-TAK1-NLK axis may act to 
modulate transcriptional responses to prevent excessive gene ex-
pression and fi  ne-tune biological effects. Further studies should 
be directed at investigating the extent to which kinases other than 
MAPK or regulation of the NLK-TAK1 axis can modulate the 
BMP-2  –  mediated activation of canonical Wnt signaling. 
  Previous work on BMP signaling has focused on the 
pSmad-dependent transcription of genes such as Indian hedge-
hog (  Seki and Hata, 2004  ), Tlx2 (  Tang et al., 1998  ), and inhibitor 
of differentiation (  Miyazono and Miyazawa, 2002  ) that are in-
volved in the regulation of cellular processes related to angio-
genesis. The ability to activate     -C suggests that BMPs can 
induce a wider array of gene targets than previously consid-
ered. This is consistent with our fi  nding that both BMP-2 and 
Wnt3a increase c-myc, VEGF, survivin, and cyclin D1, which 
are proteins that mediate hPAEC survival and proliferation. 
It is likely that the interaction between     -C and pSmad1/5/8 
and perhaps other BMP-mediated transcription factors such as 
peroxisome proliferator  –  activated receptor      ( Hansmann  et  al., 
2007  ) regulates the profi  le of expressed genes (  Labbe et al., 
2000  ;   Hu and Rosenblum, 2005  ). It is also possible that there is 
a codependency between BMP and Wnt to limit the level of ex-
pression of gene targets when both agonists are present or to 
allow gene expression to persist despite loss of function muta-
tions in BMPRII. Thus, haploinsuffi  ciency of BMPRII may be-
come more penetrant when there are concomitant alterations in 
Wnt signaling. 
  Directed migration is necessary for ECs to converge at 
sites where vessels need to be formed (  Adams and Alitalo, 
2007  ). Previous studies show that BMP-2 induces endothelial 
migration and vascular tube formation but without further in-
vestigation of the mechanisms involved (  Deckers et al., 2002  ; 
  Langenfeld and Langenfeld, 2004  ). Recent studies describing 
interactions between the cytoplasmic tail of BMPRII and pro-
teins involved in the regulation of cytoskeletal dynamics such as 
LIMK (  Foletta et al., 2003  ) and Tctex-1 (  Machado et al., 2003  ) 
suggest a functional link between BMP signaling and cell mo-
tility. It would be of interest to investigate in future studies 
whether the interaction with the cytoskeleton and with LIMK is 
lost in BMPRII mutants, as no functional studies have yet linked 
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  Materials and methods 
  Materials and reagents 
  Recombinant human BMP-2,     -tubulin antibody, protease inhibitor cock-
tail, and phosphatase inhibitor cocktail I and II were purchased from 
Sigma-Aldrich. PD98059 was obtained from EMD. Recombinant murine 
Wnt3a and human VEGF were bought from R  &  D Systems. FBS, PBS, 
MEM, optimized MEM, Medium 200, low serum growth supplement, 
gentamycin/amphotericin, polyvinylidene diﬂ   uoride membranes, Lipo-
fectamine 2000, Prolong Gold Antifade with DAPI, and Alexa Fluor 488  –   
and 592  –  labeled antibodies were obtained from Invitrogen. Anti-VEGF 
and antisurvivin were obtained from Abcam. Anti-Dvl antibody was ob-
tained from Santa Cruz Biotechnology, Inc. Anti  –  cyclin D1, Anti-pERK1/2 
and   –  total ERK  ½  , and GSK3-     were obtained from Cell Signaling Technol-
ogy. Active     -C, Rac1, and RhoA antibodies, the TCF reporter assay sys-
tem, and RhoA and Rac1 assay reagents were purchased from Millipore. 
Nucleofector II and reagents were purchased from Amaxa, Inc. Anti  –  c-myc 
antibody and tissue culture  –  treated chamber slides were obtained from BD. 
    Fig. 10   illustrates our proposed models of how BMP-2 re-
cruits canonical Wnt signaling to promote hPAEC growth and 
survival (  Fig. 10 A  ) and noncanonical signaling to induce motil-
ity (  Fig. 10 B  ). Our experiments are the fi  rst to show how BMPs 
regulate major EC functions required for normal angiogenesis 
by recruiting two Wnt signaling pathways. That BMP and Wnt 
signaling collaborate in angiogenesis is consistent with the ob-
servation that deletion of Frizzled 5 (  Ishikawa et al., 2001  ) or 
targeted endothelial deletion of BMPRIA (unpublished data) 
result in early embryonic lethality associated with a profound 
defect in yolk sac vasculature. Although it is known that BMP 
can suppress Wnt5a (  Suzuki et al., 2003  ), it now also should be 
considered that these ligands regulate common pathways fi  ne-
tuning gene expression and cellular function. 
  Figure 10.       Schema illustrating that regula-
tion of proliferation, survival, and migration in 
hPAECs depends on cross talk between BMP 
and Wnt pathways.   (A) BMP-2 and Wnt3a 
promote an increase in     -C  –  mediated tran-
scriptional activity and up-regulate gene tar-
gets involved in proliferation and survival. 
(B) However, migration is the result of a Smad1 
or, with reduced BMPRII, a Smad3-dependent 
recruitment of Dvl, which allows selective acti-
vation of RhoA, Rac1, and downward targets 
involved with cytoskeletal reorganization and 
cell motility.     JCB • VOLUME 184 • NUMBER 1 • 2009  96
lated, and a ratio of peripheral to central GFP intensity was plotted and used 
for statistical analyses. A total of four cells was used for each condition. The 
results were analyzed using Prism software (GraphPad Software, Inc.). 
  Western immunoblotting 
  hPAECs were washed three times with ice-cold 1  ×   PBS, and lysates were 
prepared by adding boiling lysis buffer (10 mM Tris HCl, 1% SDS, and 
0.2 mM PMSF) containing protease and phosphatase inhibitors, scraping 
into a 1.5-ml microcentrifuge tube, and boiling for 10 min before centrifu-
gation. Supernatants were transferred to fresh microcentrifuge tubes and 
stored at     80  °  C. The protein concentration was determined by the Lowry 
assay (Bio-Rad Laboratories). Equal amounts of protein were loaded onto 
each lane of a 4  –  12% Bis-Tris gel and subjected to electrophoresis under 
reducing conditions. After blotting, polyvinylidene diﬂ  uoride membranes 
were blocked for 1 h (5% milk powder in 0.1% TBS/Tween) and incubated 
with primary antibodies overnight at 4  °  C. The binding of secondary HRP 
antibodies was visualized by ECL or ECL Plus. Normalizing for total cell 
protein was performed by reprobing the membrane with a mouse mono-
clonal antibody against     -tubulin (Sigma-Aldrich). 
  Dvl plasmids and transfection methods 
  Plasmids encoding the WT,     DEP,     DIX, and DEP+ forms of Dvl were 
linked to a GFP tag and cloned in pCS vectors as described previously 
(  Axelrod et al., 1998  ). An adenovirus containing a dominant-negative 
form of ERK1/2 was purchased from Seven Hills Bioreagents. Mutant con-
structs of Smad1 and Smad3 containing three serine to alanine substitu-
tions in their C-terminal sequence and cloned in pCMV5 vectors were 
supplied by J. Massague (Memorial Sloan-Kettering Institute, New York, 
NY). Transfection of plasmids was performed using a Nucleofector II (pro-
gram T-23) with the Basic Endothelial Cell Nucleofection kit (Amaxa, Inc.). 
All experiments were performed 24 h after nucleofection. 
  RNAi 
  To achieve gene knockdown, siRNA duplexes speciﬁ  c for     -C (On-Target 
Plus; Invitrogen; GenBank/EMBL/DDBJ accession no.   NM_001012329   
and   NM_020248  ), ActRIIa (On-Target Plus; Invitrogen; GenBank/EMBL/
DDBJ accession no.   NM_001616  ), and BMPRII (On-Target Plus; Invitro-
gen; GenBank/EMBL/DDBJ accession no.   NM_001204  ) were transfected 
into PAECs using nucleofection as described in the previous section. Knock-
down efﬁ  ciency was evaluated 48 h after nucleofection by measuring pro-
tein levels in cell lysates using a Western immunoblot. 
  Promoter-reporter assays 
  For measurements of     -C  –  mediated changes in gene expression, we used 
a TOPﬂ  ash/FOPﬂ  ash TCF/LEF reporter assay. The TOPﬂ  ash construct con-
tains a promoter with eight TCF/LEF1-binding domains found in the pro-
moters of     -C target genes linked to a luciferase gene, whereas the 
FOPﬂ  ash construct has mutated binding sites and serves as a negative con-
trol. hPAECs were transfected with either plasmid in a Nucleofector II (pro-
gram T-23) using the Basic Endothelial Cell Nucleofection kit. After 24 h in 
starvation media, cells were stimulated, and luciferase production was 
measured 6 h later in a luminometer using the Dual Luciferase kit (Pro-
mega) according to the manufacturer  ’  s protocol. Renilla plasmid (Promega) 
cotransfection was used to control for transfection efﬁ  ciency. 
  RhoA and Rac1 pull-down assays 
  hPAECs were washed three times with ice-cold 1  ×   PBS. Cell lysates were 
prepared by adding 500   μ  l of ice-cold magnesium lysis buffer (10 mM Tris 
HCl, 1.0% SDS, 0.2 mM PMSF, and 100  ×   protease and phosphatase in-
hibitor cocktails I and II; Millipore) to the cells and scraping into a 1.5-ml 
microcentrifuge tube on ice before cold centrifugation at 14,000 rpm for 
10 min. Supernatants were transferred to fresh microcentrifuge tubes and 
stored at     80  °  C. 
  Active forms of RhoA or Rac1 were precipitated using glutathione 
beads containing rhotekin or PAK1, respectively, according to the manu-
facturer  ’  s protocol (Millipore). In brief, lysates were incubated with slurry 
containing the glutathione beads for 1 h at 4  °  C with constant rotation. At 
the end of this period, beads were precipitated by centrifuging lysates at 
14,000 relative centrifuge force for 20 s. After washing three times with 
ice-cold buffer, beads were resuspended in Laemmli buffer, boiled, and 
subjected to Western immunoblot analysis as described above. 
  Digitally enhanced video differential interference contrast microscopy 
  48 h after transfection, cells were allowed to attach and spread on 
glass coverslips in the incubator and viewed on an inverted microscope 
Cytodex 3 beads, HRP-conjugated rabbit and mouse secondary antibod-
ies, and ECL and ECL Plus kits were ordered from GE Healthcare. Dual Lu-
ciferase and caspase 3/7 assay kits were obtained from Promega. Labtek 
II chambered coverslips and all siRNA duplexes were purchased from 
Thermo Fisher Scientiﬁ  c. 
  Cell culture 
  Primary hPAECs from large vessels (Invitrogen; and ScienCell) were grown 
in EC media supplemented with 2% FBS, 1   μ  g/ml hydrocortisone, 10 ng/ml 
human epidermal growth factor, 3 ng/ml basic ﬁ  broblast growth factor, 
10   μ  g/ml heparin, and gentamycin/amphotericin subcultured at a 1:4 
ratio in 100-mm dishes (Corning) and used at passages 4  –  8. Cells were 
starved in Medium 200 with 0.1% FBS and gentamycin/amphotericin for 
24 h before adding the agonist or the vehicle. Avoiding medium changes 
allows consistent determination of     -C and EC proliferation in response to 
the dose of BMP-2 used. 
  Proliferation assay 
  hPAECs were seeded at 25,000 cells per well on 24-well plates in growth 
medium and allowed to adhere overnight. Cells were washed three times 
with PBS and incubated in starvation media for 24 h followed by stimula-
tion with agonists for 24 h. Cells were trypsinized and counted in a hemo-
cytometer (Bright-Line; Hausser Scientiﬁ  c). 
  Survival assay 
  For caspase 3/7 assays, cells were seeded in a 96-well plate (4 wells per 
condition and 5,000 cells per well), allowed to attach overnight, and incu-
bated for 24 h in serum-free media to induce apoptosis in the presence or 
absence of BMP-2 or Wnt3a. Cells were incubated for 1 h in 100   μ  l of 
Caspase 3/7 Luciferase Reagent Mix (Promega), and total luminescence 
was measured in a 20/20 luminometer (Turner Biosystems, Inc.). 
  Migration assay 
  Cytodex 3 cell culture beads were suspended in 1  ×   PBS, autoclaved, and 
gently agitated in Petri dishes containing 10 ml of cell media followed by 
gentle agitation. Next, 1 ml hPAECs (10 
5   cells/ml) was added and incu-
bated overnight to allow attachment to the beads. Once cells had grown 
to conﬂ  uence over the beads, 1 ml of cell-coated beads was added to 
a solution containing MEM and vitronectin, pH 7.6, and allowed to solid-
ify. Cells were incubated for 30  –  60 min followed by the addition of 1.5 ml 
of cell media, with or without agonist, to the surface of each gel. After 
48 h, cell migration was quantiﬁ  ed by dividing each dish into four quad-
rants and selecting three beads in each for further analyses. Migration was 
quantiﬁ  ed by the distance each cell traveled from the center of the bead. 
The mean distance traveled per quadrant was then used to calculate the 
mean distance migrated by cells in each plate. A microscope (DMRIRBA; 
Leica) with a headed channel switch Plan Apochromat 40  ×   NA 0.85 ob-
jective was used. 
  Confocal microscopy 
  Cells were plated in four-chamber polystyrene glass slides (15,000 cells 
per chamber). For stimulation experiments, cells were starved for 24 h 
and stimulated with BMP as speciﬁ  ed in the ﬁ  gure legends. Next, cells 
were ﬁ  xed for 10 min in 4% paraformaldehyde followed by three washes 
with PBS. For experiments of native Dvl distribution in hPAECs, cells were 
permeabilized with ice-cold 1  ×   PBS containing 0.1% Triton X-100 and 
donkey serum for 20 min followed by overnight incubation with goat anti-
Dvl (Santa Cruz Biotechnology, Inc.) at RT, washed in 1  ×   PBS, and incu-
bated with Alexa Fluor 555 donkey anti  –  goat antibody (Invitrogen) for 
1 h at RT followed by Alexa Fluor 488  –  labeled phalloidin for 20 min to 
stain actin ﬁ  laments. For experiments of cells nucleofected with the various 
GFP-tagged Dvl constructs, actin staining was performed by incubating 
Alexa Fluor 555  –  phalloidin (Invitrogen) for 20 min after permeabilization 
with 0.1% Triton X-100 in PBS. Before mounting, slides were treated with 
Gold Antifade solution containing DAPI and stored at 4  °  C until analysis. 
  Confocal analysis was performed on a confocal laser-scanning 
microscope (SP2 AOBS; Leica) using a headed channel switch Plan Apo-
chromat 63  ×   NA 1.32  –  0.60 oil objective to locate areas of interest in the 
slides, and image acquisition was performed using the confocal build 
1347 software (version 2.5; Leica) installed in the Leica confocal PC (Win-
dows XP operating system). Images were processed and saved in JPEG for-
mat using Photoshop Creative Suite 2 (Adobe Systems). 
  To quantify distribution of GFP in PAECs transfected with the various 
Dvl constructs, GFP signal intensity in the cellular processes and the per  i-
nuclear area was measured in six randomly selected sectors using the ImageJ 
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(Axiovert 35; Carl Zeiss, Inc.) with a Plan Apochromat 100  ×   oil immersion 
lens (Carl Zeiss, Inc.) and a short distance condenser. The microscope is 
also equipped with a heated stage, differential interference contrast optics, 
and epiﬂ  uorescence. Filters and light paths were controlled with a ﬁ  lter 
wheel and shutters (Ludl Electronic Products Ltd.). For GFP visualization, a 
single band excitation ﬁ  lter for FITC was used in combination with Pinkel#1 
beam splitter and emission ﬁ  lter (Chroma Technology Corp.). Tissue culture 
medium without phenol red was kept warm and buffered in a CO  2   incuba-
tor. The stage temperature was kept at 37  °  C with an automatic thermostat. 
Images were collected using a charge-coupled device camera (C2400; 
B  &  W) with on-chip integration and a digital image processor (Argus 20; 
PerkinElmer). Acquired images were assembled in temporal sequences 
using Openlab software (PerkinElmer) and saved as QuickTime (Apple, Inc.) 
videos. The distance traveled by the cells was calculated by recording the 
position of the nucleus in individual frames using ImageJ software and plot-
ting on an x  –  y axis followed by measurement of distance between each of 
the individual points. Total distance was obtained from the total sum of 
these values. Speed was measured by dividing total distance over time 
(10 h) using the following formula: S = D/t, where S = speed, D = distance 
and, t = time. A total of four cells was used for each measurement. 
  Matrigel plug angiogenesis assay in SCID mice 
  Animal experiments were approved by Stanford University  ’  s Institutional 
Review Board under the guidelines of the American Physiological Society. 
Matrigel plugs containing hPAECs were prepared as described previously 
(  Skovseth et al., 2007  ), and 48 h after transfection,     1.0   ×   10 
6   cells were 
suspended in chilled 500   μ  l/plug of Matrigel Growth Factor Reduced solu-
tion (BD), to which recombinant BMP-2 diluted to a ﬁ  nal concentration of 
10 ng/ml or carrier was added. Plugs were implanted in the back of SCID 
mice (Charles River Laboratories) anesthetized by subcutaneous injection 
of a ketamine/xylazine cocktail. For each experimental condition, a total 
of four plugs was implanted in each animal and allowed to remain in place 
for 14 d. At the end of this period, the animals were humanely killed, and 
the solid Matrigel plugs were removed and ﬁ  xed in 4% paraformaldehyde 
for 24 h and embedded in parafﬁ  n. Hematoxylin and eosin (H  &  E) sections 
were prepared. Unstained tissue samples were double labeled with Alexa 
Fluor 488  –  labeled anti  –  human CD31 and Alexa Fluor 555  –  labeled anti  –
  mouse CD31 to identify human and murine ECs, respectively, along with 
DAPI to stain nuclei. 10 images per slide were captured using the 40  ×   ob-
jective of an immunoﬂ  uorescence microscope (DM RA2; Leica) and ana-
lyzed via Openlab software. The presence of microvessels (deﬁ  ned  as 
tubes ﬁ  lled with red blood cells) was documented using H  &  E sections, and 
the number of human and murine cells per condition was quantiﬁ  ed using 
the aforementioned immunoﬂ  uorescence techniques. 
  Statistical analysis 
  Values from multiple experiments are expressed as mean   ±   SEM. Statistical 
signiﬁ  cance was determined using one-way analysis of variance followed 
by Bonferroni  ’  s multiple comparison tests unless stated otherwise. A value 
of P   <   0.05 was considered signiﬁ  cant. The number of experiments and the 
sample number in each group are indicated in the ﬁ  gure legends. 
  Online supplemental material 
  Fig. S1 shows semiquantitative RT-PCR data for all 19 known Wnt ligands 
found in hPAECs at baseline. Fig. S2 shows confocal images of hPAECs 
stimulated with BMP-2 for 1 h and labeled with a primary antibody spe-
ciﬁ  c for     -C and an Alexa Fluor 488  –  labeled secondary antibody. Fig. S3 
shows that hPAECs treated with BMPRII siRNA fail to accumulate     -C when 
stimulated with BMP-2, an event that correlates with failure to phosphory-
late both ERK1/2 and GSK3-    . Fig. S4 shows the loss of BMP-2  –  mediated 
    -C accumulation and transcriptional activity in the presence of dominant-
negative ERK (    ERK). Fig. S5 demonstrates both the lack of impact of the 
Dvl mutant constructs on BMP-mediated     -C accumulation and the periph-
eral redistribution of Dvl in BMP-2  –   or Wnt3a-stimulated PAECs. Videos 
1 and 2 show hPAECs transfected with WT Dvl at baseline (Video 1) and 
in the presence of BMP-2 (Video 2). Videos 3 and 4 show hPAECs trans-
fected with     DEP exposed to the same conditions as described for Videos 
1 and 2. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200806049/DC1. 
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